-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HPG-1860 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. HPG-1860 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: HPG-1860 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HPG-1860 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HPG-1860 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HPG-1860 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:HPG-1860 is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TRGFT-201 in Hematopoietic Stem Cell Transplantation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TRGFT-201 in Hematopoietic Stem Cell Transplantation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TRGFT-201 in Hematopoietic Stem Cell Transplantation Drug Details: TRGFT-201 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Talimogene Laherparepvec in Merkel Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Talimogene Laherparepvec in Merkel Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Talimogene Laherparepvec in Merkel Cell Carcinoma Drug Details: Talimogene laherparepvec...
-
Company Profile
Silvercorp Metals Inc – Company Profile
Silvercorp Metals Inc (Silvercorp) is a mining exploration company. It carries out the acquisition, exploration, development, and mining of precious and base metal mineral properties. The company mines various metals, including gold, silver, lead, and zinc in China. It operates seven underground mines such as SGX, HZG, HPG, TLP, LME, LMW and DCG. Silvercorp also operates the BYP gold-lead-zinc project in Hunan Province and GC silver-lead-zinc project in Guangdong Province. It sells products to local smelters and companies, which carry...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HPG-1860
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HPG-1860 Drug Details HPG-1860 is under development for the treatment of non-alcoholic steatohepatitis (NASH)...